Micro Therapeutics Stock Climbs 17%

Micro Therapeutics Inc. stock climbed 17% Tuesday after the maker of treatments for neurovascular and peripheral vascular diseases said it entered into a distribution alliance with Guidant Corp.

Guidant may invest as much as $10 million in Micro Therapeutics in the form of convertible debt, equity and a credit line.

Micro Therapeutics stock rose 94 cents a share to $6.44 on the Nasdaq market.